{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T04:56:57Z","timestamp":1770526617176,"version":"3.49.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2002,4,1]],"date-time":"2002-04-01T00:00:00Z","timestamp":1017619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":4125,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2002,4]]},"DOI":"10.1016\/s1535-6108(02)00044-2","type":"journal-article","created":{"date-parts":[[2002,10,11]],"date-time":"2002-10-11T11:58:07Z","timestamp":1034337487000},"page":"247-255","source":"Crossref","is-referenced-by-count":374,"title":["The contribution of VHL substrate binding and HIF1-\u03b1 to the phenotype of VHL loss in renal cell carcinoma"],"prefix":"10.1016","volume":"1","author":[{"given":"Jodi K","family":"Maranchie","sequence":"first","affiliation":[]},{"given":"James R","family":"Vasselli","sequence":"additional","affiliation":[]},{"given":"Joseph","family":"Riss","sequence":"additional","affiliation":[]},{"given":"Juan S","family":"Bonifacino","sequence":"additional","affiliation":[]},{"given":"W.Marston","family":"Linehan","sequence":"additional","affiliation":[]},{"given":"Richard D","family":"Klausner","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S1535-6108(02)00044-2_BIB1","first-page":"2210","article-title":"Transforming growth factor beta1 is a target for the von Hippel-Lindau tumor suppressor and a critical growth factor for clear cell renal carcinoma","volume":"59","author":"Ananth","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/S1535-6108(02)00044-2_BIB2","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1101\/gad.13.1.64","article-title":"Functional role of p35srj, a novel p300\/CBP binding protein, during transactivation by HIF-1","volume":"13","author":"Bhattacharya","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/S1535-6108(02)00044-2_BIB3","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1242\/jeb.201.8.1197","article-title":"Erythropoietin","volume":"201","author":"Bunn","year":"1998","journal-title":"J. Exp. Biol."},{"key":"10.1016\/S1535-6108(02)00044-2_BIB4","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1148\/radiology.194.3.7862955","article-title":"von Hippel-Lindau disease","volume":"194","author":"Choyke","year":"1995","journal-title":"Radiology"},{"key":"10.1016\/S1535-6108(02)00044-2_BIB5","doi-asserted-by":"crossref","first-page":"25733","DOI":"10.1074\/jbc.M002740200","article-title":"Hypoxia inducible factor-\u03b1 binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein","volume":"275","author":"Cockman","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S1535-6108(02)00044-2_BIB6","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1126\/science.7660122","article-title":"Inhibition of transcription elongation by the VHL tumor suppressor protein","volume":"269","author":"Duan","year":"1995","journal-title":"Science"},{"key":"10.1016\/S1535-6108(02)00044-2_BIB7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0092-8674(01)00507-4","article-title":"C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation","volume":"107","author":"Epstein","year":"2001","journal-title":"Cell"},{"key":"10.1016\/S1535-6108(02)00044-2_BIB8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0014-5793(99)01476-3","article-title":"Cloning and expression pattern of EPAS1 in the chicken embryo. Colocalization with tyrosine hydroxylase","volume":"462","author":"Favier","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/S1535-6108(02)00044-2_BIB9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0925-4773(97)00674-6","article-title":"HRF, a putative basic helix-loop-helix-PAS-domain transcription factor is closely related to hypoxia-inducible factor-1 \u03b1 and developmentally expressed in blood vessels","volume":"63","author":"Flamme","year":"1997","journal-title":"Mech. Dev."},{"key":"10.1016\/S1535-6108(02)00044-2_BIB10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0002-9440(10)65541-1","article-title":"Up-regulation of vascular endothelial growth factor in stromal cells of hemangioblastomas is correlated with up-regulation of the transcription factor HRF\/HIF-2\u03b1","volume":"153","author":"Flamme","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/S1535-6108(02)00044-2_BIB11","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1128\/MCB.16.9.4604","article-title":"Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1","volume":"16","author":"Forsythe","year":"1996","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/S1535-6108(02)00044-2_BIB12","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1093\/hmg\/3.12.2169","article-title":"Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma","volume":"3","author":"Foster","year":"1994","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/S1535-6108(02)00044-2_BIB13","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1054\/bjoc.2001.2018","article-title":"Relation of hypoxia inducible factor 1\u03b1 and 2\u03b1 in operable non-small cell lung cancer to angiogenic\/molecular profile of tumours and survival","volume":"85","author":"Giatromanolaki","year":"2001","journal-title":"Br. J. Cancer"},{"key":"10.1016\/S1535-6108(02)00044-2_BIB14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/ng0594-85","article-title":"Mutations of the VHL tumour suppressor gene in renal carcinoma","volume":"7","author":"Gnarra","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/S1535-6108(02)00044-2_BIB15","doi-asserted-by":"crossref","first-page":"9700","DOI":"10.1073\/pnas.91.21.9700","article-title":"Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma","volume":"91","author":"Herman","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1535-6108(02)00044-2_BIB16","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nm0895-822","article-title":"Tumour suppression by the human von Hippel-Lindau gene product","volume":"1","author":"Iliopoulos","year":"1995","journal-title":"Nat. Med."},{"key":"10.1016\/S1535-6108(02)00044-2_BIB17","doi-asserted-by":"crossref","first-page":"10595","DOI":"10.1073\/pnas.93.20.10595","article-title":"Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein","volume":"93","author":"Iliopoulos","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1535-6108(02)00044-2_BIB18","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1126\/science.1059817","article-title":"HIF\u03b1 targeted for VHL-mediated destruction by proline hydroxylation","volume":"292","author":"Ivan","year":"2001","journal-title":"Science"},{"key":"10.1016\/S1535-6108(02)00044-2_BIB19","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.1059796","article-title":"Targeting of HIF-\u03b1 to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation","volume":"292","author":"Jaakkola","year":"2001","journal-title":"Science"},{"key":"10.1016\/S1535-6108(02)00044-2_BIB20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0925-4773(98)00038-0","article-title":"Expression of ARNT, ARNT2, HIF1 \u03b1, HIF2 \u03b1 and Ah receptor mRNAs in the developing mouse","volume":"73","author":"Jain","year":"1998","journal-title":"Mech. Dev."},{"key":"10.1016\/S1535-6108(02)00044-2_BIB21","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1126\/science.284.5414.657","article-title":"Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase","volume":"284","author":"Kamura","year":"1999","journal-title":"Science"},{"key":"10.1016\/S1535-6108(02)00044-2_BIB22","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.7660130","article-title":"Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C","volume":"269","author":"Kibel","year":"1995","journal-title":"Science"},{"key":"10.1016\/S1535-6108(02)00044-2_BIB23","doi-asserted-by":"crossref","first-page":"5902","DOI":"10.1128\/MCB.19.9.5902","article-title":"The von Hippel-Lindau tumor suppressor gene inhibits hepatocyte growth factor\/scatter factor-induced invasion and branching morphogenesis in renal carcinoma cells","volume":"19","author":"Koochekpour","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/S1535-6108(02)00044-2_BIB24","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S1535-6108(02)00043-0","article-title":"Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein","volume":"1","author":"Kondo","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/S1535-6108(02)00044-2_BIB25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/hum.1994.5.1-19","article-title":"Improved methods of retroviral vector transduction and production for gene therapy","volume":"5","author":"Kotani","year":"1994","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/S1535-6108(02)00044-2_BIB26","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1006\/dbio.1999.9253","article-title":"Defective vascularization of HIF-1\u03b1-null embryos is not associated with VEGF deficiency but with mesenchymal cell death","volume":"209","author":"Kotch","year":"1999","journal-title":"Dev. Biol."},{"key":"10.1016\/S1535-6108(02)00044-2_BIB27","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1038\/sj.onc.1203938","article-title":"Up-regulation of hypoxia-inducible factors HIF-1\u03b1 and HIF-2\u03b1 under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function","volume":"19","author":"Krieg","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/S1535-6108(02)00044-2_BIB28","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/20459","article-title":"The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis","volume":"399","author":"Maxwell","year":"1999","journal-title":"Nature"},{"key":"10.1016\/S1535-6108(02)00044-2_BIB29","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S1097-2765(00)80096-9","article-title":"The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix","volume":"1","author":"Ohh","year":"1998","journal-title":"Mol. Cell"},{"key":"10.1016\/S1535-6108(02)00044-2_BIB30","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/35017054","article-title":"Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein","volume":"2","author":"Ohh","year":"2000","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/S1535-6108(02)00044-2_BIB31","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1073\/pnas.94.6.2156","article-title":"The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins","volume":"94","author":"Pause","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1535-6108(02)00044-2_BIB32","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1073\/pnas.95.3.993","article-title":"The von Hippel-Lindau tumor suppressor gene is required for cell cycle exit upon serum withdrawal","volume":"95","author":"Pause","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1535-6108(02)00044-2_BIB33","doi-asserted-by":"crossref","first-page":"9533","DOI":"10.1073\/pnas.96.17.9533","article-title":"Studying interactions of four proteins in the yeast two-hybrid system","volume":"96","author":"Pause","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1535-6108(02)00044-2_BIB34","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/ki.1997.78","article-title":"Complex role of protein phosphorylation in gene activation by hypoxia","volume":"51","author":"Salceda","year":"1997","journal-title":"Kidney Int."},{"key":"10.1016\/S1535-6108(02)00044-2_BIB35","doi-asserted-by":"crossref","first-page":"5447","DOI":"10.1128\/MCB.12.12.5447","article-title":"A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation","volume":"12","author":"Semenza","year":"1992","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/S1535-6108(02)00044-2_BIB36","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1749-6632.1999.tb09241.x","article-title":"Regulation of cardiovascular development and physiology by hypoxia-inducible factor 1","volume":"874","author":"Semenza","year":"1999","journal-title":"Ann. N Y Acad. Sci."},{"key":"10.1016\/S1535-6108(02)00044-2_BIB37","first-page":"2299","article-title":"Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein","volume":"56","author":"Siemeister","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/S1535-6108(02)00044-2_BIB38","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1093\/carcin\/22.9.1363","article-title":"Hepatocyte growth factor signalling stimulates hypoxia inducible factor- 1 (HIF-1) activity in HepG2 hepatoma cells","volume":"22","author":"Tacchini","year":"2001","journal-title":"Carcinogenesis"},{"key":"10.1016\/S1535-6108(02)00044-2_BIB39","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1101\/gad.11.1.72","article-title":"Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells","volume":"11","author":"Tian","year":"1997","journal-title":"Genes Dev."},{"key":"10.1016\/S1535-6108(02)00044-2_BIB40","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1101\/gad.12.21.3320","article-title":"The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development","volume":"12","author":"Tian","year":"1998","journal-title":"Genes Dev."},{"key":"10.1016\/S1535-6108(02)00044-2_BIB41","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1182\/blood.V92.7.2260","article-title":"Induction of endothelial PAS domain protein-1 by hypoxia","volume":"92","author":"Wiesener","year":"1998","journal-title":"Blood"},{"key":"10.1016\/S1535-6108(02)00044-2_BIB42","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/0470868716.ch15","article-title":"The HIF pathway","volume":"240","author":"Wykoff","year":"2001","journal-title":"Novartis Found. Symp."},{"key":"10.1016\/S1535-6108(02)00044-2_BIB43","first-page":"5830","article-title":"Overexpression of hypoxia-inducible factor 1\u03b1 in common human cancers and their metastases","volume":"59","author":"Zhong","year":"1999","journal-title":"Cancer Res."}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610802000442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610802000442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T15:25:22Z","timestamp":1622042722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535610802000442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,4]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,4]]}},"alternative-id":["S1535610802000442"],"URL":"https:\/\/doi.org\/10.1016\/s1535-6108(02)00044-2","relation":{},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2002,4]]}}}